{
  "id": 17233574,
  "title": "Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF",
  "url": "https://urgent.news/2026/10/30/can-glp-1s-fatten-your-portfolio-we-examine-the-vaneck-pharmaceutical",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-30T14:09:02.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/etfs/2026/10/30/can-glp-1s-fatten-your-portfolio-we-examine-the-vaneck-pharmaceutical-etf-vs-state-street-spdr-pharmaceuticals-etf/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "VanEck's concentrated 26-stock portfolio delivered stronger five-year returns and lower volatility, while State Street's 62-holding fund offers broader diversification and lower fees.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}